Skip to main content
Clinical Trials/NCT00581672
NCT00581672
Completed
Not Applicable

Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men

Memorial Sloan Kettering Cancer Center3 sites in 1 country224 target enrollmentJuly 25, 2010
ConditionsProstate Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
224
Locations
3
Primary Endpoint
To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer.
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study is being done to see if a standard tool used to check anxiety in white men works well for Black men. The tool is used only for men who have prostate cancer. It is meant to see how the cancer affects men. If the investigators have a good tool, it is more likely that the investigators can help those who have high levels of anxiety. This test is known as the Memorial Anxiety Scale for Prostate Cancer (also called the MAX-PC).

Registry
clinicaltrials.gov
Start Date
July 25, 2010
End Date
May 3, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Patients who are being monitored by PSA tests, who will have a PSA test done on the day of their current clinic visit or prior to their clinic visit, but prior to being informed of the results
  • Diagnosis of prostate cancer
  • Ethnicity: Black, African-American, or of African descent (and will include those men who identify as Black and Hispanic).
  • Ability to comprehend and complete questionnaires in English

Exclusion Criteria

  • Major psychopathology or cognitive impairment likely, in the judgment of the research staff, to interfere with the participation or completion of the protocol
  • Other non-Black or non-African-American ethnic groups

Outcomes

Primary Outcomes

To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer.

Time Frame: within one to three weeks of receiving their PSA scores from their physician

Secondary Outcomes

  • To explore the prevalence of distress, anxiety, and depression in Black men with prostate cancer.(within one to three weeks of receiving their PSA scores from their physician)

Study Sites (3)

Loading locations...

Similar Trials